Sana Biotechnology, Inc.SANANASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank29
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P29
Within normal range
vs 2Y Ago
-0.6x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-10.91%
Q3 202511.09%
Q2 202531.97%
Q1 2025-3.17%
Q4 20248.99%
Q3 202411.48%
Q2 202410.80%
Q1 2024-26.31%
Q4 202318.24%
Q3 2023-8.08%
Q2 202325.82%
Q1 2023-4.21%
Q4 2022-17.39%
Q3 20229.35%
Q2 20228.02%
Q1 202229.42%
Q4 2021-118.08%
Q3 2021-24.48%
Q2 202118.75%
Q1 2021-32.89%
Q4 2020-0.13%
Q3 2020-12.42%
Q2 2020-12.93%
Q1 202012.57%
Q4 20190.00%